3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
2
Recruiting
1
Completed
1
Sponsor Class
UNKNOWN
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Glioblastoma
203
Brain Neoplasms
94
Gliosarcoma
93
Glioma
88
Central Nervous System Neoplasms
78
Astrocytoma
66
Oligodendroglioma
45
Melanoma
37
Medulloblastoma
18
Neuroblastoma
17
Neoplasm Metastasis
14
Ependymoma
13
Neoplasms
10
Choroid Plexus Neoplasms
10
Sarcoma
9
Recurrence
9
Optic Nerve Glioma
9
Familial ependymoma
9
Carcinoma, Non-Small-Cell Lung
9
Ovarian Neoplasms
8
Lung Neoplasms
8
Spinal Cord Neoplasms
7
Breast Neoplasms
7
Uveal Melanoma
6
Sarcoma, Ewing
6
Rhabdoid Tumor
6
Pinealoma
6
Neuroectodermal Tumors, Primitive
6
Unspecified Adult Solid Tumor, Protocol Specific
5
Small Cell Lung Carcinoma
5
Interventions
Pemetrexed
5
Topotecan
3
Dexamethasone
3
Bevacizumab
3
osimertinib
2
Vitamin B 12
2
Trastuzumab
2
Spinal Puncture
2
Radiotherapy
2
Methotrexate
2
Folic Acid
2
Cytarabine
2
Busulfan
2
trioctyl phosphine oxide
1
trastuzumab deruxtecan
1
tipifarnib
1
merphos
1
mafosfamide
1
immunotoxin LMB-7
1
epothilone B
1
avelumab
1
aflutinib
1
XL647
1
Transplantation, Autologous
1
Temozolomide
1
Rituximab
1
Referral and Consultation
1
Radiotherapy, Intensity-Modulated
1
Nivolumab
1
Mental Status and Dementia Tests
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Meningeal Carcinomatosis
×
Temozolomide
×
Clear all
NCT02654106
2017-06-06
SRTRBM
ChineseAMS
Phase 2
Completed
65 enrolled